Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionUmb Bank N A/mo
Latest Disclosed Ownership2,424 shares
Latest Disclosed Value $ 194,114
Umb Bank N A/mo reports 5.35% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 11, 2026 - Umb Bank N A/mo filed a 13F-HR form disclosing ownership of 2,424 shares of Edwards Lifesciences Corporation (MX:EW) valued at $194,114 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,561 shares of Edwards Lifesciences Corporation. This represents a change in shares of -5.35% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,424 -137 -5.35 194 -11.01 0.0024
2026-02-13 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,561 101 4.11 218 14.14 0.0029
2025-11-04 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,460 -559 -18.52 191 -19.07 0.0028
2025-07-11 2025-06-30 13F/A-01 EDWARDS LIFESCIENCES COM 28176E108 3,019 96 3.28 236 11.85 0.0037
2025-07-10 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,923 0 212 0.0031
2025-04-14 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,923 -1,837 -38.59 212 -40.06 0.0035
2025-01-16 2024-12-31 13F Edwards Lifesciences COM 28176E108 4,760 -4,906 -50.76 352 -44.74 0.0056
2024-10-09 2024-09-30 13F Edwards Lifesciences COM 28176E108 9,666 -111,752 -92.04 638 -94.32 0.0099
2024-07-29 2024-06-30 13F Edwards Lifesciences COM 28176E108 121,418 3,760 3.20 11,215 -0.25 0.1839
2024-04-26 2024-03-31 13F Edwards Lifesciences COM 28176E108 117,658 47,130 66.82 11,243 109.09 0.1781
2024-01-23 2023-12-31 13F Edwards Lifesciences COM 28176E108 70,528 58,737 498.15 5,378 558.95 0.0786
2023-10-18 2023-09-30 13F Edwards Lifesciences COM 28176E108 11,791 -4,791 -28.89 817 -47.83 0.0131
2023-07-25 2023-06-30 13F Edwards Lifesciences COM 28176E108 16,582 -297 -1.76 1,564 12.03 0.0237
2023-04-11 2023-03-31 13F Edwards Lifesciences COM 28176E108 16,879 -2,533 -13.05 1,396 139,500.00 0.0223
2023-01-10 2022-12-31 13F Edwards Lifesciences COM 28176E108 19,412 -19,310 -49.87 1 -99.97 0.0229
2022-10-13 2022-09-30 13F Edwards Lifesciences COM 28176E108 38,722 -100,443 -72.18 3,199 -75.83 0.0539
2022-07-20 2022-06-30 13F Edwards Lifesciences COM 28176E108 139,165 3,903 2.89 13,234 -16.89 0.2061
2022-04-22 2022-03-31 13F Edwards Lifesciences COM 28176E108 135,262 -135,736 -50.09 15,923 -54.65 0.2107
2022-02-09 2021-12-31 13F Edwards Lifesciences COM 28176E108 270,998 28,151 11.59 35,108 27.70 0.4434
2021-10-18 2021-09-30 13F Edwards Lifesciences COMMON 28176E108 242,847 5,133 2.16 27,492 11.67 0.6184
2021-07-26 2021-06-30 13F Edwards Lifesciences COMMON 28176E108 237,714 -258 -0.11 24,620 23.69 0.5636
2021-04-15 2021-03-31 13F Edwards Lifesciences COMMON 28176E108 237,972 9,555 4.18 19,904 -4.49 0.4865
2021-02-04 2020-12-31 13F Edwards Lifesciences COMMON 28176E108 228,417 173,165 313.41 20,839 445.81 0.5611
2020-10-16 2020-09-30 13F Edwards Lifesciences COMMON 28176E108 55,252 0 0.00 3,818 0.00 0.1183
2020-07-16 2020-06-30 13F Edwards Lifesciences COMMON 28176E108 55,252 55,252 3,818 0.1183
2017-04-24 2017-03-31 13F Edwards Lifesciences COMMON 28176E108 0 -30,499 -100.00 0 -100.00
2017-01-18 2016-12-31 13F Edwards Lifesciences COMMON 28176E108 30,499 2,874 10.40 2,858 -14.17 0.1052
2016-10-28 2016-09-30 13F Edwards Lifesciences COMMON 28176E108 27,625 -3,940 -12.48 3,330 5.78 0.1342
2016-07-26 2016-06-30 13F Edwards Lifesciences COMMON 28176E108 31,565 13,359 73.38 3,148 96.01 0.1325
2016-04-20 2016-03-31 13F Edwards Lifesciences COMMON 28176E108 18,206 18,206 1,606 0.0685
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.